Skip to content

About Us
Our Technology
Clinical
Leadership Team
- Board
- Management Team
Investor Centre
Recruitment
Contact Us

About Us
Our Technology
Clinical
Leadership Team
- Board
- Management Team
Investor Centre
Recruitment
Contact Us

Day: March 9, 2021

$500m Cancer team reassembled

Join Our Mailing List

Our mission is to develop receptor-targeted oncolytic RNA immunotherapies that improve outcomes for patients with cancers that are difficult to treat

A clinical-stage company developing receptor-targeted oncolytic RNA immunotherapies for cancers with high unmet need.

Twitter Linkedin

Company

About Us
Our Technology
Clinical
Leadership Team
- Board
- Management Team
Investor Centre
Recruitment
Contact Us

About Us
Our Technology
Clinical
Leadership Team
- Board
- Management Team
Investor Centre
Recruitment
Contact Us

© 2026 ImmVirX Pty Ltd • Website developed by Noise